Long-Term Safety and Tolerability of ProSavin, a Lentiviral Vector-Based Gene Therapy for Parkinsons Disease: A Dose Escalation, Open-Label, Phase 1/2 TrialLancet 383:1138-1146,1107, Palfi, S.,et al, 2014